Literature DB >> 17217945

Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors.

Laura E Wise1, Christopher C Shelton, Benjamin F Cravatt, Billy R Martin, Aron H Lichtman.   

Abstract

In the present study, we investigated whether anandamide produces its behavioral effects through a cannabinoid CB(1) receptor mechanism of action. The behavioral effects of anandamide were evaluated in mice that lacked both fatty acid amide hydrolase (FAAH) and cannabinoid CB(1) receptors (DKO) as compared to FAAH (-/-), cannabinoid CB(1) (-/-), and wild type mice. Anandamide produced analgesia, catalepsy, and hypothermia in FAAH (-/-) mice, but failed to elicit any of these effects in the other three genotypes. In contrast, anandamide decreased locomotor behavior regardless of genotype, suggesting the involvement of multiple mechanisms of action, including its products of degradation. These findings indicate that the cannabinoid CB(1) receptor is the predominant target mediating anandamide's behavioral effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17217945     DOI: 10.1016/j.ejphar.2006.11.002

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  16 in total

1.  Determination of naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in mouse blood and tissue after inhalation exposure to 'buzz' smoke by HPLC/MS/MS.

Authors:  Justin L Poklis; Dorra Amira; Laura E Wise; Jason M Wiebelhaus; Brenda J Haggerty; Aron H Lichtman; Alphonse Poklis
Journal:  Biomed Chromatogr       Date:  2012-03-08       Impact factor: 1.902

2.  Thermoregulatory phenotype of the Trpv1 knockout mouse: thermoeffector dysbalance with hyperkinesis.

Authors:  Andras Garami; Eszter Pakai; Daniela L Oliveira; Alexandre A Steiner; Samuel P Wanner; M Camila Almeida; Vladimir A Lesnikov; Narender R Gavva; Andrej A Romanovsky
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

3.  Metabolomics activity screening for identifying metabolites that modulate phenotype.

Authors:  Carlos Guijas; J Rafael Montenegro-Burke; Benedikt Warth; Mary E Spilker; Gary Siuzdak
Journal:  Nat Biotechnol       Date:  2018-04-05       Impact factor: 54.908

Review 4.  Enzymatic pathways that regulate endocannabinoid signaling in the nervous system.

Authors:  Kay Ahn; Michele K McKinney; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2008-04-23       Impact factor: 60.622

5.  FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.

Authors:  Katherine W Falenski; Andrew J Thorpe; Joel E Schlosburg; Benjamin F Cravatt; Rehab A Abdullah; Tricia H Smith; Dana E Selley; Aron H Lichtman; Laura J Sim-Selley
Journal:  Neuropsychopharmacology       Date:  2010-03-31       Impact factor: 7.853

6.  Assessment of the pharmacology and tolerability of PF-04457845, an irreversible inhibitor of fatty acid amide hydrolase-1, in healthy subjects.

Authors:  Gai Ling Li; Helen Winter; Rosalin Arends; Gary W Jay; Vu Le; Tim Young; John P Huggins
Journal:  Br J Clin Pharmacol       Date:  2012-05       Impact factor: 4.335

7.  The endogenous cannabinoid system modulates nicotine reward and dependence.

Authors:  Lisa L Merritt; B R Martin; C Walters; A H Lichtman; M Imad Damaj
Journal:  J Pharmacol Exp Ther       Date:  2008-05-01       Impact factor: 4.030

8.  Excitation of cutaneous C nociceptors by intraplantar administration of anandamide.

Authors:  Carl Potenzieri; Thaddeus S Brink; Donald A Simone
Journal:  Brain Res       Date:  2009-03-10       Impact factor: 3.252

9.  Methanandamide attenuates cocaine-induced hyperthermia in rats by a cannabinoid CB1-dopamine D2 receptor mechanism.

Authors:  Bruce A Rasmussen; Esther Kim; Ellen M Unterwald; Scott M Rawls
Journal:  Brain Res       Date:  2009-01-18       Impact factor: 3.252

10.  N-arachidonyl maleimide potentiates the pharmacological and biochemical effects of the endocannabinoid 2-arachidonylglycerol through inhibition of monoacylglycerol lipase.

Authors:  James J Burston; Laura J Sim-Selley; John P Harloe; Anu Mahadevan; Raj K Razdan; Dana E Selley; Jenny L Wiley
Journal:  J Pharmacol Exp Ther       Date:  2008-08-05       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.